Disclaimer
The stock market is subject to significant volatility and inherent risks. Investing in stocks involves potential losses and is not guaranteed to generate profits. Prices of stocks can fluctuate unpredictably, We do not give any buy/sell tips. This article is for Educational purposes only.
Hamps Bio IPO is a highly anticipated Initial Public Offering (IPO) set to raise ₹6.22 crores through a fresh issue of 12.2 lakh shares. This fixed-price IPO offers shares at ₹51 per share, with a minimum lot size of 2,000 shares. Retail investors need to invest at least ₹102,000 for one lot, while High Net Worth Individuals (HNIs) must invest ₹204,000 for two lots. The IPO will be listed on the BSE SME platform, and the key dates include the opening on December 13, 2024, closing on December 17, 2024, allotment finalization on December 18, 2024, and the tentative listing on December 20, 2024.
Investors interested in Hamps Bio IPO grey market premium (GMP) and IPO subscription status can monitor market trends to understand pre-listing sentiments. The IPO allotment status will be available on BSE or the registrar's website, ensuring transparency and easy tracking. It’s important to watch Hamps Bio IPO, watch updates, and stay informed on the IPO allotment status BSE.
The IPO’s key players include Marwadi Chandarana Intermediaries Brokers Pvt. Ltd. as the Book Running Lead Manager, Bigshare Services Pvt. Ltd. as the Registrar, and Pure Broking as the Market Maker. For a detailed understanding of the IPO, including its potential market impact, investors can refer to the Hamps Bio IPO RHP. Whether you're tracking the IPO full form, grey market trends, or subscription status, this IPO offers a promising opportunity to engage in the SME market.
| IPO Date | December 13, 2024 to December 17, 2024 |
|---|---|
| Listing Date | December 20, 2024 |
| Face Value | ₹10 per share |
| Price | ₹51 per share |
| Lot Size | 2000 Shares |
| Total Issue Size | 1,220,000 shares (aggregating up to ₹6.22 Cr) |
| Fresh Issue | 1,220,000 shares (aggregating up to ₹6.22 Cr) |
| Issue Type | Fixed Price Issue IPO |
| Listing At | BSE SME |
| Shareholding pre issue | 3,136,000 |
| Shareholding post issue | 4,356,000 |
| Market Maker portion | 62,000 shares |
| Market Maker | Pure Broking |
| IPO Open Date | Friday, December 13, 2024 |
|---|---|
| IPO Close Date | Tuesday, December 17, 2024 |
| Basis of Allotment | Wednesday, December 18, 2024 |
| Initiation of Refunds | Thursday, December 19, 2024 |
| The credit of Shares to Demat | Thursday, December 19, 2024 |
| Listing Date | Friday, December 20, 2024 |
| Cut-off time for UPI mandate confirmation | 5 PM on December 17, 2024 |
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 2000 | ₹102,000 |
| Retail (Max) | 1 | 2000 | ₹102,000 |
| HNI (Min) | 2 | 4,000 | ₹204,000 |
| Investor Category | Shares Offered |
|---|---|
| Anchor Investor Shares Offered | - |
| Market Maker Shares Offered | 62,000 (5.08%) |
| Other Shares Offered | 5,79,000 (47.46%) |
| Retail Shares Offered | 5,79,000 (47.46%) |
| Total Shares Offered | 12,20,001 (100%) |
| Period Ended | 31 Oct 2024 | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 |
|---|---|---|---|---|
| Assets | 644.00 | 514.77 | 395.87 | 364.31 |
| Revenue | 436.42 | 650.13 | 558.49 | 534.46 |
| Profit After Tax | 34.08 | 50.07 | 35.90 | 12.15 |
| Net Worth | 370.78 | 337.42 | 136.30 | 100.57 |
| Reserves and Surplus | 57.18 | 141.42 | -13.70 | -49.43 |
| Total Borrowing | 138.31 | 104.52 | 173.77 | 204.31 |
| Amount in ₹ Lakhs | ||||
Hamps Bio IPO presents a promising investment opportunity with its fixed-price issue and strategic listing on the BSE SME platform. With a share price set at ₹51 and a minimum investment requirement of ₹102,000 for retail investors, the IPO is designed to cater to both small and high-net-worth investors. Key dates, such as the opening on December 13, 2024, and the tentative listing on December 20, 2024, provide a clear timeline for those interested in tracking its progress.
Investors are encouraged to monitor the Hamps Bio IPO grey market premium (GMP) and subscription status for insights into pre-listing sentiments. The allotment process is transparent, and the IPO allotment status can be checked through the BSE or the registrar’s website. With key roles played by Marwadi Chandarana Intermediaries, Bigshare Services, and Pure Broking, the IPO is backed by experienced market players.
For those looking to diversify their portfolio or explore opportunities in the SME sector, Hamps Bio IPO offers a structured and reliable investment pathway. Stay updated with the latest IPO watch GMP trends and refer to the Hamps Bio IPO RHP for comprehensive details.
